about
Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patientsBrain metastases from stomach cancer - The role of different treatment modalities and efficacy of palliative radiotherapy.Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancerIdentification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot studyInfluence of interfraction motion on margins for radiotherapy of gastric cancerAssociation between Stereotactic Radiotherapy and Death from Brain Metastases of Epithelial Ovarian Cancer: a Gliwice Data Re-Analysis with PenalizationProtection of organs at risk during neoadjuvant chemoradiotherapy for gastric cancer based on a comparison between conformal and intensity-modulated radiation therapy."Mistletoe sign": probably a new dermoscopic descriptor for melanoma in situ and melanocytic junctional nevus in the inflammatory stage."Better do not touch" and other superstitions concerning melanoma: the cross-sectional web-based survey.Melanoma awareness and prevalence of dermoscopic examination among internet users: a cross-sectional survey.The Comparison and Estimation of the Prognostic Value of Lipid Profiles in Patients With Prostate Cancer Depends on Cancer Stage Advancement.Can we obtain planning goals for conformal techniques in neoadjuvant and adjuvant radiochemotherapy for gastric cancer patients?Radiation-induced injury of the exocrine pancreas after chemoradiotherapy for gastric cancer.Melanoma as a surprising solution to the puzzle of intestinal obstruction.Radiotherapy induced hip joint avascular necrosis-Two cases reportMagnetic resonance spectroscopic evaluation of brain tissue metabolism after irradiation for pediatric brain tumors in long-term survivors: a report of two cases.Primary Locations of Malignant Melanoma Lesions Depending on Patients’ Gender and Age18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer RadiotherapyModerately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy.Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.Dermoscopy of skin metastases from breast cancer and of the orange peel type ("peau d'orange"): a report of two cases.Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment.Appraisal of Basic-Hemostatic Markers in Lung Cancer Patients During Follow-Up Care After Radiotherapy TreatmentThe Effect of Radiotherapy on the Concentration of Plasma Lipids in Elderly Prostate Cancer PatientsThe Correlation of Blood Parameters with Size in Cases of Neoplastic TumorBehaviors of active sunbeds users and their knowledge on the potential health risks; results of cross-sectional study in Poland.Evaluation of delivered dose changes during radiation therapyThe tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II studyA pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancerNeoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized studyPrimary melanoma in rare locations: clinical and dermatoscopic featuresLipid Status During Combined Treatment in Prostate Cancer Patients
P50
Q34100321-1802829B-F2B5-4892-A292-569C23386219Q34719526-86C3D418-35AC-4E06-A268-27E56AED4A73Q35625394-D6D892E2-9428-4ABA-86D0-8B8A9B44104CQ35777594-7678D2E3-E970-47C5-9241-F03725997FBFQ36295443-642AAA90-F3BE-4E09-99DE-281C27F592D1Q36382664-DCEDCEFB-99F3-4ED8-A258-3BEFF23CEA06Q37002803-DF6A05AF-D3F5-4772-975F-A84379265495Q37381943-8B3B2E7F-1686-4212-A358-26550F6793E3Q37416290-CB91A950-4E84-4EA8-97E6-32C8FF6293EFQ37531834-084415FB-A6E8-4D06-8032-224AEF59A1EFQ40115477-F51EB8EB-FFEB-4FB0-BDE5-419209C4F18BQ40959913-188FBBE0-0B5C-46EF-977F-BC6318527C35Q41017812-E9285382-8462-4FC9-AC3A-B84EF76E9460Q42319972-E37D64BD-A607-45F9-AF33-3FF83FA094F1Q42794334-C22F492C-AF78-443E-A1F5-968CFE98DDCFQ43265276-F1B4D6B7-D7C7-4F4D-BF81-39175F9D034AQ47418815-E16A4D18-9376-4266-8C03-AEDE5B719731Q47418845-64D3F324-39AA-4490-854E-C856992F9EC5Q51914996-9B423B9C-A590-4658-9A6C-F09738D57F9EQ53172925-FBA9D477-8AC5-4D49-A340-1DE68AB88A93Q54393185-C47A1D33-9FCD-45E1-B242-27B1C184C140Q55047973-173B8310-7605-48BE-8AF8-8E632339C891Q60311310-6116E7E3-6526-44F1-AF37-BAC6E7FFB50FQ64087147-17BAB887-FADA-4CAC-AF07-940B1DE63BB0Q64235715-22333C01-2CDA-4841-8C88-BAC80135D1F0Q64993780-73032E5F-9874-41F6-A614-AF29A8383614Q77397670-016F4DD4-250C-410E-9BC5-993526E7D011Q79741716-08018345-B140-4151-AB5F-8FBB00BAD7F3Q83858357-8610086E-C465-458B-B46A-BE684ADAF820Q86604304-C3EF8499-FFCC-486A-82BC-AC7B22D187FAQ87409528-C0C04EEC-8488-4119-A913-BC465C8CEF07Q90324494-682CE90A-DCF3-4831-8599-8C176CC1A150
P50
description
researcher
@en
wetenschapper
@nl
name
J Wydmański
@en
J Wydmański
@nl
type
label
J Wydmański
@en
J Wydmański
@nl
prefLabel
J Wydmański
@en
J Wydmański
@nl
P106
P31
P496
0000-0002-2879-3781